Chester County News and Community Website
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, has announced that its Investigational New Drug (IND) application for APR-1051 has been cleared by the U.S. Food …
FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company, recently reported an increase in both research and development (R&D) and general administrative expenses for the fourth quarter and …
Savara Inc. Reports Increased Expenses, Anticipates Positive Data from IMPALA-2 Trial Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) is set to participate in the 26th Annual Barclays Global Healthcare Conference. The event, scheduled for March 14, 2024, will feature a fireside …
Savara Inc. to Address Barclays Global Healthcare Conference on Rare Respiratory Diseases Read More
BRISTOL, PA — Bathroom retreat specialist Robern has announced the addition of two new ceiling-suspended mirrors, Arch and Pill Sculpt, to its extensive decorative mirror portfolio. These innovative designs offer …
Robern Unveils Innovative Hanging Mirrors, Adding a New Dimension to Bathroom Decor Read More
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, is set to present an abstract on …
Onconova to Unveil New Rigosertib Study Results at Cancer Research Meeting Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a biopharmaceutical company focused on discovering, developing, and commercializing a cure for patients suffering from chronic Hepatitis B virus infection, has announced …
Arbutus Biopharma to Participate in Prominent Investor Conferences Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN), has released its financial results for the quarter and year ending December 31, 2023. The report indicates a slight dip in revenue, but highlights …
Optinose Reports Financial Dip Despite Potential Breakthrough in Chronic Sinusitis Treatment Read More
NEWTOWN, PA — Neurotech company Helius Medical Technologies, Inc. (Nasdaq: HSDT) will present at the 36th Annual ROTH Conference on Monday, March 18, 2024, at 1:30 pm PT in Laguna …
Helius Medical Technologies to Showcase Neurotech Innovations at the 36th Annual ROTH Conference Read More
NEW HOPE, PA — In an ongoing endeavor to combat hypertension, Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has unveiled the latest results from a pressure-volume (PV) loop study of its …
Orchestra BioMed’s AVIM Therapy Demonstrates Promising Results in Controlling Hypertension Read More NEWTOWN, PA — Helius Medical Technologies Inc. (Nasdaq: HSDT) has announced a significant milestone in its mission to improve the lives of those suffering from gait impairment due to multiple …
Helius Medical Technologies Secures Key CMS Coding for Innovative PoNS Therapy Read More